Vanguard Group’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $561K | Hold |
|
|||||
|
2024
Q4 | $665K | Hold |
|
|||||
|
2024
Q3 | $451K | Sell |
|
|||||
|
2024
Q2 | $759K | Sell |
|
|||||
|
2024
Q1 | $8.29M | Buy |
|
|||||
|
2023
Q4 | $5.72M | Hold |
|
|||||
|
2023
Q3 | $3.63M | Buy |
|
|||||
|
2023
Q2 | $4.03M | Sell |
|
|||||
|
2023
Q1 | $3.1M | Buy |
|
|||||
|
2022
Q4 | $6.9M | Buy |
|
|||||
|
2022
Q3 | $1.04M | Buy |
|
|||||
|
2022
Q2 | $1.1M | Buy |
|
|||||
|
2022
Q1 | $2.07M | Sell |
|
|||||
|
2021
Q4 | $3.22M | Sell |
|
|||||
|
2021
Q3 | $4.95M | Sell |
|
|||||
|
2021
Q2 | $5.27M | Sell |
|
|||||
|
2021
Q1 | $8M | Buy |
|
|||||
|
2020
Q4 | $9.66M | Buy |
|
|||||
|
2020
Q3 | $5.39M | Buy |
|
|||||
|
2020
Q2 | $6.17M | Sell |
|
|||||
|
2020
Q1 | $3.99M | Buy |
|
|||||
|
2019
Q4 | $9.23M | Sell |
|
|||||
|
2019
Q3 | $7.55M | Buy |
|
|||||
|
2019
Q2 | $20.7M | Sell |
|
|||||
|
2019
Q1 | $22.9M | Buy |
|
|||||
|
2018
Q4 | $17.3M | Buy |
|
|||||
|
2018
Q3 | $24.4M | Buy |
|
|||||
|
2018
Q2 | $26.9M | Buy |
|
|||||
|
2018
Q1 | $24.6M | Buy |
|
|||||
|
2017
Q4 | $17.3M | Buy |
|
|||||
|
2017
Q3 | $12.9M | Buy |
|
|||||
|
2017
Q2 | $9.42M | Buy |
|
|||||
|
2017
Q1 | $2.36M | Buy |
|
|||||
|
2016
Q4 | $2.59M | Buy |
|
|||||
|
2016
Q3 | $2.93M | Buy |
|
|||||
|
2016
Q2 | $2.86M | Buy |
|
|||||
|
2016
Q1 | $1.4M | Buy |
|
|||||
|
2015
Q4 | $1.24M | Buy |
|
|||||
|
2015
Q3 | $1.17M | Hold |
|
|||||
|
2015
Q2 | $1.66M | Buy |
|
|||||
|
2015
Q1 | $1.73M | Buy |
|
|||||
|
2014
Q4 | $1.47M | Buy |
|
|||||
|
2014
Q3 | $1.41M | Buy |
|
|||||
|
2014
Q2 | $1.24M | Buy |
|
|||||
|
2014
Q1 | $2.05M | Buy |
|